IP Library Granted Patent US 10,272,122
Granted Patent B2
US 10,272,122 · App. 15/132,286 · Granted Apr 30, 2019

Patent

Inventors: Marika Mikelsaar (Tartu, EE); Epp Songisepp (Tartu, EE); Pirje Hütt (Tartu, EE); Imbi Smidt (Tartumaa, EE); Kai Truusalu (Tartu, EE); Merle Rätsep (Tartu, EE); Siiri Koljalg (Tartu, EE); Jelena Stsepetova (Tartu, EE); Kalle Kilk (Tartu, EE); Mihkel Zilmer (Tartu, EE); Epp Sepp (Tallinn, EE); Raik-Hiio Mikelsaar (Tartu, EE)
Assignee: BIOCC OÜ
A61K35/747A23C9/1234A23C19/061A23C19/062A23K10/18A23L33/135C12N1/20C12R1/25A23C19/054A23V2002/00A23Y2220/67A61K31/047A61K2035/115
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,272,122
App. No.
15/132,286
Granted
Apr 30, 2019
Kind
B2
Abstract

A microorganism strain Lactobacillus plantarum Inducia DSM 21379 for use as hypocholesterolemic, antimicrobial and anti-oxidative agent and as enhancer of the natural defense potential of a subject. L. plantarum Inducia is used for reducing the level of LDL-cholesterol in blood for preventing the cholesterol metabolism disorders and cardiovascular disorders. L. plantarum Inducia enhances simultaneously the natural defense potential and cellular immunity, and as anti-oxidative agent enhances anti-oxidative activity of blood by reducing the level of oxidized low density lipoprotein (ox-LDL). The strain is also used as an antimicrobial agent for lowering risk of Clostridium difficile associated diarrhea (CDAD) by preventing germination of C. difficile spores and by suppressing proliferation of its vegetative cells. The compositions comprising L. plantarum Inducia decrease the levels of LDL-cholesterol and ox-LDL in blood, enhance the natural defense potential and lower risk of CDAD. The composition may further comprise xylitol.

Claims (1)

1. A method for decreasing the level of LDL-cholesterol in blood, and simultaneously for reducing the level of oxidized low density lipoprotein (ox-LDL) of blood of a subject by administering a daily dose of Lactobacillus plantarum Inducia DSM 21379 at 10 9 CFU to a subject in need thereof during 3 weeks.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2020
From: BIOCC OÜ
To: NORDWISE BIOTECH OÜ
Reel/Frame 054239/0409 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 048129 FRAME 0284. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Aug 2, 2019
From: TERVISLIKU PIIMA BIOTEHNOLOOGIATE ARENDUSKESKUS OÜ (BIO-COMPETENCE CENTRE OF HEALTHY DAIRY PRODUCTS)
To: BIOCC OÜ
Reel/Frame 050114/0832 →
CHANGE OF NAME Recorded Jan 24, 2019
From: TERVISLIKU PIIMA BIOTEHNOLOOGIATE ARENDUSKESKUS OÜ (BIO-COMPETENCE CENTRE OF HEALTHY DAIRY PRODUCTS)
To: BIOCCO OÜ
Reel/Frame 048129/0284 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 039853 FRAME 0693. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Oct 7, 2016
From: MIKELSAAR, MARIKA; SONGISEPP, EPP; HÜTT, PIRJE; SMIDT, IMBI; TRUUSALU, KAI; RÄTSEP, MERLE; KÕLJALG, SIIRI; STSEPETOVA, JELENA; KILK, KALLE; ZILMER, MIHKEL; SEPP, EPP; MIKELSAAR, RAIK-HIIO
To: TERVISLIKU PIIMA BIOTEHNOLOOGIATE ARENDUSKESKUS OÜ (BIO-COMPETENCE CENTRE OF HEALTHY DAIRY PRODUCTS)
Reel/Frame 040365/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2016
From: MIKELSAAR, MARIKA; SONGISEPP, EPP; HÜTT, PIRJE; SMIDT, IMBI; TRUUSALU, KAI; RÄTSEP, MERLE; KÕLJALG, SIIRI; STSEPETOVA, JELENA; KILK, KALLE; ZILMER, MIHKEL; SEPP, EPP; MIKELSAAR, RAIK-HIIO
To: TERVISLIKU PIIMA BIOTEHNOLOOGIATE ARENDUSKESKUS OÜ (BIO-COMPETENCE CENTRE OF HEALTH DIARY PRODUCTS)
Reel/Frame 039853/0693 →
Priority Claims (1)
EE 200800027 · May 13, 2008 · national
Continuity (3)
Division 14244284 · Apr 3, 2014
Continuation In Part 12992862
Related Publication 20160296570A1 · Oct 13, 2016